FeesSafety
Pluang+

Hyperliquid's HYPE token jumps 13% as plans emerge for U.S. regulated perpetual contracts.

Market News
29 Oct 2026, 16:12 WIB
Tokenpost
View Source
Bullish
Hyperliquid's HYPE token jumps 13% as plans emerge for U.S. regulated perpetual contracts.

Hyperliquid's HYPE token surged over 13%, breaking above $90, following news that Intercontinental Exchange (ICE), owner of the NYSE, plans to collaborate with Trade.xyz to introduce perpetual contract products into a regulated U.S. market. Trade.xyz is part of Hyperliquid's HIP-3 ecosystem, which focuses on perpetual products linked to pre-IPO assets. While HYPE's price rise reflects market optimism, the partnership plan between ICE and Trade.xyz is still in development and not yet launched. This move could expand regulated derivatives trading options in the U.S. market through Hyperliquid's ecosystem.

Hyperliquid's HYPE token is the story's subject, here is Pluang's market snapshot as of Oct 29, 2026 20:05 WIB: Of 50 major cryptocurrencies, 19 rose and 30 fell. Notable movers include AXS at Rp16.872 with a -3.35% change, THETA at Rp3.147 down 3.26%, and UNI at Rp131.595 up 2.96%.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
23 minutes ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
23 minutes ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
1 hour ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
1 hour ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App